APA (7th ed.) Citation

TW, F., DL, C., K, S., KE, W., R, U., SD, H., & FA, M. (2021). Evidence-based use of scalable biomarkers to increase diagnostic efficiency and decrease the lifetime costs of autism. Autism research : official journal of the International Society for Autism Research, 14(6), 1271. https://doi.org/10.1002/aur.2498

Chicago Style (17th ed.) Citation

TW, Frazier, Coury DL, Sohl K, Wagner KE, Uhlig R, Hicks SD, and Middleton FA. "Evidence-based Use of Scalable Biomarkers to Increase Diagnostic Efficiency and Decrease the Lifetime Costs of Autism." Autism Research : Official Journal of the International Society for Autism Research 14, no. 6 (2021): 1271. https://doi.org/10.1002/aur.2498.

MLA (9th ed.) Citation

TW, Frazier, et al. "Evidence-based Use of Scalable Biomarkers to Increase Diagnostic Efficiency and Decrease the Lifetime Costs of Autism." Autism Research : Official Journal of the International Society for Autism Research, vol. 14, no. 6, 2021, p. 1271, https://doi.org/10.1002/aur.2498.